Zobrazeno 1 - 10
of 300
pro vyhledávání: '"антикоагулянты"'
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 53-58 (2023)
Relevance. Diseases of the cardiovascular system remain one of the main causes of death worldwide. The incidence of cardiovascular and circulatory diseases increased by one third between 1990 and 2010. The prevalence of atrial fibrillation (AF) rang
Externí odkaz:
https://doaj.org/article/bf115da72ff749ec92398b2389cc170e
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 4, Pp 38-49 (2023)
Aim. To conduct a pharmacoeconomic analysis of the use of the drug Eliquis® (apixaban), belonging to direct oral anticoagulants (DOACs), for the treatment and prevention of deep vein thrombosis (DVT) and/or pulmonary embolism (PE), including in pati
Externí odkaz:
https://doaj.org/article/6ff807e2571742b38079ad62f6a0f807
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 55-68 (2022)
Intracerebral hemorrhage (ICH), which is a form of hemorrhagic stroke, is an extremely serious disease. This pathology is characterized by very high levels of disability and mortality. Despite the improvement in the treatment of those diseases that c
Externí odkaz:
https://doaj.org/article/7b12447e21ad4802a92cd519ed199225
Autor:
Елена Викторовна Мальцева, Марина Афанасьевна Соколовская, Дмитрий Юрьевич Братчиков, Ольга Викторовна Доманская
Publikováno v:
Мать и дитя в Кузбассе, Vol 23, Iss 3, Pp 175-181 (2022)
The article is devoted to the current topic in neonatology – the development of thrombosis. The incidence of neonatal thrombosis and its risk factors are shown. The questions of diagnostics and therapeutic approaches to the development of neonatal
Externí odkaz:
https://doaj.org/article/ebff15f5681f43b9b481c3d003af12bb
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 4S, Pp 18-22 (2020)
Hospitalized patients with COVID-19 who have not previously received DOAK by it is not advisable to prescribe POAC for the prevention of thrombosis in patients with COVID-19 due to the lack of clinical trial results, significant potential interaction
Externí odkaz:
https://doaj.org/article/c642c348f7d74c5f821007ddf6ae9220
Publikováno v:
Эндодонтия Today, Vol 18, Iss 2, Pp 4-9 (2020)
Aim. To study the state of oral mucosa and rationale of Its changes In patients with a laboratory-con^rmed diagnosis of SARS-CoV-2, moderate severity.Materials and methods. A retrospective single-center study was conducted on patients who were In the
Externí odkaz:
https://doaj.org/article/00e08bd5672349fe8d2f6e870152cbc7
Autor:
A. V. Samorodov, K. N. Zolotukhin
Publikováno v:
Креативная хирургия и онкология, Vol 10, Iss 2, Pp 137-142 (2020)
Introduction. In patients with COVID-19, acute pulmonary lesion grows on inflammation and microvascular thrombosis. Thromboinflammation may develop outside alveolar endothelium and affect endothelium of the heart, kidneys, intestine and other vital o
Externí odkaz:
https://doaj.org/article/e23f05ee362e491b80ea66f690ec1693
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 66-72 (2019)
Tis article presents a literature review of hepatotoxicity of new oral anticoagulants which was obtained by different methods options of pharmacovigilance. Te overview includes 35 information sources 24 articles, 4 methodic or regulatory guidelines,
Externí odkaz:
https://doaj.org/article/df906578779f45c29a130ac442bdd7f0
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 1 (2020)
Данный выпуск журнала «Качественная клиническая практика» посвящён нескольким научным направлениям изучения лекарственных препарато
Externí odkaz:
https://doaj.org/article/b02d92c07b504fb485e7824944fdc82b
Autor:
I. S. Yavelov
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 53-60 (2018)
Practical approaches to use of oral anticoagulants for prevention and treatment of thrombotic and thromboembolic complications in patients with atrial fibrillation, venous thromboembolism and coronary heart disease are considered. Comparison of main
Externí odkaz:
https://doaj.org/article/292b3c579acb4960800c3de15b479268